President Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in two ...

Despite former President Donald Trump’s threat of a 200% tariff on imported drugs during a cabinet meeting, pharmaceutical investors have shown surprisingly positive sentiment this week. Despite ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

After U.S. President Donald Trump said Mexican leaders are 'petrified' of cartels, Mexican President Sheinbaum responded.

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

Pharma prepares for looming tariffs, as the US president signals a phased increase starting Aug. 1, but the official starting ...

Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...

President Trump has threatened to increase Mexico’s tariff rate to 30 percent starting Aug. 1, claiming the country hasn’t ...

In April, Trump announced a 25% tariff on U.S. imports from South Korea as part of his broader “Liberation Day” trade package ...

President Trump hosted congressional leaders and families affected by the fentanyl epidemic on Wednesday for a signing ...

Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.